Effects of crinofizin administration in experimental diseases with protein anabolism disorders. Studies in the rat.
The effects of the treatment with Crinofizin, a pineal peptide extract, on certain parameters of the protein metabolism, altered in rat by prolonged deficiency of endogenous insulin (study on animals with streptozotocinic diabetes) or by administration of large doses of cortisone, were studied. The results demonstrated the anabolic effects of the pineal extract treatment which improved the diabetic syndrome and counteracted some catabolic effects subsequent to insulin deficiency, such as weight loss and decrease in the nucleic acid concentration in the liver, or to cortisone excess, such as nitrogen loss. The data obtained open new prospects for the use of Crinofizin in the management of degenerative endocrine diseases through anabolizing hormones failure or catabolizing hormones excess.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002417:Cattle; D003348:Cortisone / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004231:Diuresis; D006029:Glycosuria; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009584:Nitrogen / Q000652:urine; D010455:Peptides / Q000494:pharmacology*; D010870:Pineal Gland; D011506:Proteins / Q000378:metabolism*; D012313:RNA / Q000378:metabolism; D051381:Rats; D014508:Urea / Q000652:urine
D010455:Peptides; D011506:Proteins; C016320:polypeptide pineal extract; D012313:RNA; D014508:Urea; D004247:DNA; D009584:Nitrogen; D003348:Cortisone